University of California San Francisco
Helen Diller Family Comprehensive Cancer Center
Quan-Yang Duh, MD

Quan-Yang Duh, MD

Professor, Department of Surgery, UCSF

Selected Publications

  1. Chomsky-Higgins KH, Rochefort HM, Seib CD, Gosnell JE, Shen WT, Duh QY, Suh I. Recombinant Parathyroid Hormone Versus Usual Care: Do the Outcomes Justify the Cost? World J Surg. 2018 02; 42(2):431-436.
    View on PubMed
  2. Seib CD, Rochefort H, Chomsky-Higgins K, Gosnell JE, Suh I, Shen WT, Duh QY, Finlayson E. Association of Patient Frailty With Increased Morbidity After Common Ambulatory General Surgery Operations. JAMA Surg. 2018 Feb 01; 153(2):160-168.
    View on PubMed
  3. Duh QY, Suh I. It's Complicated: How Often are Patients with Primary Aldosteronism Cured After Adrenalectomy? World J Surg. 2018 02; 42(2):464-465.
    View on PubMed
  4. Asban A, Kluijfhout WP, Drake FT, Beninato T, Wang E, Chomsky-Higgins K, Shen WT, Gosnell JE, Suh I, Duh QY. Trends of genetic screening in patients with pheochromocytoma and paraganglioma: 15-year experience in a high-volume tertiary referral center. J Surg Oncol. 2018 Jan 08.
    View on PubMed
  5. Anuwong A, Ketwong K, Jitpratoom P, Sasanakietkul T, Duh QY. Safety and Outcomes of the Transoral Endoscopic Thyroidectomy Vestibular Approach. JAMA Surg. 2018 Jan 01; 153(1):21-27.
    View on PubMed
  6. Gosnell JE, Duh QY. Medullary Thyroid Carcinoma-We Should Do Better. JAMA Surg. 2018 Jan 01; 153(1):59.
    View on PubMed
  7. Poorman CE, Ethun CG, Postlewait LM, Tran TB, Prescott JD, Pawlik TM, Wang TS, Glenn J, Hatzaras I, Shenoy R, Phay JE, Keplinger K, Fields RC, Jin LX, Weber SM, Salem A, Sicklick JK, Gad S, Yopp AC, Mansour JC, Duh QY, Seiser N, Solórzano CC, Kiernan CM, Votanopoulos KI, Levine EA, Staley CA, Poultsides GA, Maithel SK. A Novel T-Stage Classification System for Adrenocortical Carcinoma: Proposal from the US Adrenocortical Carcinoma Study Group. Ann Surg Oncol. 2018 Feb; 25(2):520-527.
    View on PubMed
  8. Beninato T, Kluijfhout WP, Drake FT, Khanafshar E, Gosnell JE, Shen WT, Duh QY, Suh I. Squamous differentiation in papillary thyroid carcinoma: a rare feature of aggressive disease. J Surg Res. 2018 Mar; 223:39-45.
    View on PubMed
  9. Chomsky-Higgins K, Seib C, Rochefort H, Gosnell J, Shen WT, Kahn JG, Duh QY, Suh I. Less is more: cost-effectiveness analysis of surveillance strategies for small, nonfunctional, radiographically benign adrenal incidentalomas. Surgery. 2018 Jan; 163(1):197-204.
    View on PubMed
  10. Wang TS, Duh QY. Editorial: Volume-outcome relationship in adrenal surgery. Surgery. 2018 Jan; 163(1):165-166.
    View on PubMed
  11. Duh QY, Gosnell JE. Improvement of TNM Staging for Medullary Thyroid Cancer. JAMA Surg. 2017 Sep 01; 152(9):876-877.
    View on PubMed
  12. Sosa JA, Duh QY, Doherty G. Striving for Clarity About the Best Approach to Thyroid Cancer Screening and Treatment: Is the Pendulum Swinging Too Far? JAMA Surg. 2017 Aug 01; 152(8):721-722.
    View on PubMed
  13. Kluijfhout WP, Pasternak JD, Gosnell JE, Shen WT, Duh QY, Vriens MR, de Keizer B, Hope TA, Glastonbury CM, Pampaloni MH, Suh I. 18F Fluorocholine PET/MR Imaging in Patients with Primary Hyperparathyroidism and Inconclusive Conventional Imaging: A Prospective Pilot Study. Radiology. 2017 08; 284(2):460-467.
    View on PubMed
  14. Kluijfhout WP, Drake FT, Pasternak JD, Beninato T, Mitmaker EJ, Gosnell JE, Shen WT, Suh I, Freise CE, Duh QY. De novo thyroid cancer following solid organ transplantation-A 25-year experience at a high-volume institution with a review of the literature. J Surg Oncol. 2017 Feb; 115(2):105-108.
    View on PubMed
  15. Kluijfhout WP, Pasternak JD, Beninato T, Drake FT, Gosnell JE, Shen WT, Duh QY, Allen IE, Vriens MR, de Keizer B, Hope TA, Suh I. Diagnostic performance of computed tomography for parathyroid adenoma localization; a systematic review and meta-analysis. Eur J Radiol. 2017 Mar; 88:117-128.
    View on PubMed
  16. Kluijfhout WP, Duh QY. Unilateral Clearance for Primary Hyperparathyroidism in Selected Patients with Multiple Endocrine Neoplasia Type 1: Reply. World J Surg. 2017 01; 41(1):329.
    View on PubMed
  17. Kim Y, Margonis GA, Prescott JD, Tran TB, Postlewait LM, Maithel SK, Wang TS, Glenn JA, Hatzaras I, Shenoy R, Phay JE, Keplinger K, Fields RC, Jin LX, Weber SM, Salem A, Sicklick JK, Gad S, Yopp AC, Mansour JC, Duh QY, Seiser N, Solorzano CC, Kiernan CM, Votanopoulos KI, Levine EA, Poultsides GA, Pawlik TM. Curative Surgical Resection of Adrenocortical Carcinoma: Determining Long-term Outcome Based on Conditional Disease-free Probability. Ann Surg. 2017 01; 265(1):197-204.
    View on PubMed
  18. Kluijfhout WP, Beninato T, Drake FT, Vriens MR, Gosnell J, Shen WT, Suh I, Liu C, Duh QY. Unilateral Clearance for Primary Hyperparathyroidism in Selected Patients with Multiple Endocrine Neoplasia Type 1. World J Surg. 2016 12; 40(12):2964-2969.
    View on PubMed
  19. Beninato T, Kluijfhout WP, Drake FT, Lim J, Kwon JS, Xiong M, Shen WT, Gosnell JE, Liu C, Suh I, Duh QY. Resection of Pheochromocytoma Improves Diabetes Mellitus in the Majority of Patients. Ann Surg Oncol. 2017 May; 24(5):1208-1213.
    View on PubMed
  20. Kluijfhout WP, Pasternak JD, Drake FT, Beninato T, Shen WT, Gosnell JE, Suh I, C L, Duh QY. Application of the new American Thyroid Association guidelines leads to a substantial rate of completion total thyroidectomy to enable adjuvant radioactive iodine. Surgery. 2017 01; 161(1):127-133.
    View on PubMed

Go to UCSF Profiles, powered by CTSI